Dr. Francesca Cicchetti

Chief Scientific Officer and Co-Founder

  • Professor for the department of Psychiatry & Neurosciences, of Laval University’s Medical School in Québec City.

  • Completed a postdoctoral fellowship at Harvard Medical School in the field of cell replacement therapy for neurodegenerative disorders.

  • Published over 80 manuscripts in various high impact journals such as PNAS, Annals of Neurology, Acta Neuropathologica, Trends in Pharmacology, and Brain.

Sylvain Chrétien

President, Chief Executive Officer and Co-Founder

 

  • An accomplished executive with over 34 years of domestic & international experience in product search and development.

  • Proven track record in market identification, strategic positioning, and P&L management for small, medium and global pharmaceutical organizations.

  • A result-driven leader and seasoned pharma-biotech operator with demonstrated success in raising capital.

Louis-Régis Tremblay

Co-founder and Director ICD.D

 

  • Successful career as an executive in the field of plastics (IPL) and aluminum (Alcoa) supervising mega-projects between $1.0B to $4.0B

  • Chairman of the board of Albecour

  • Former board member of Desjardins Capital

Dr. Claude Piché

Chairman of the Board



  • CEO and co-founder of Locemia Solutions, Chairman of Zucara Therapeutics inc.

  • Biotech executive veteran with over 30 years of industry experience.

  • Sharing his valuable expertise as a drug developer expert

Dr. Ben Cadieux

Key Senior Advisor



  • Biotech executive veteran with over 29 years of academic and industry experience in the US (Amgen, Raptor, Genzyme etc…)

  • Post doctoral fellowship in neurosurgery at University of California San Francisco (UCSF)

  • Lead the clinical development program of Cysteamine in brain degenerative disorders at Raptor Pharmaceuticals

Jo Van Betsbrugge

Drug Development Consultant/Expert

 

  • Synthetic organic chemist, specializing in the development and manufacture of small molecule and peptide drugs.

  • Extensive experience with the development of solid oral, intranasal and injectable dosage forms.

  • Member of the American Chemical Society and the American Association of Pharmaceutical Scientists.

Dolorès Carballo

Senior Project Manager

 

  • More than 15 years of experience in the pharmaceutical industry, specializing in clinical project management and product development.

  • Extensive expertise in clinical project management, cross-functional coordination, and monitoring study performance.

  • Proven track record in enhancing operational processes and managing relationships with external partners (CRO, CMO, etc.).